CenTrial Logo

Clinical Trial evaluates Aerobic vs Balance Training for Cerebellar Ataxia

by


Clinical trial finds aerobic exercise most beneficial for cerebellar ataxia patients

Cerebellar ataxia is a neurological disorder that affects the cerebellum, which is part of the brain responsible for controlling coordination, balance, and fine motor skills. It is characterized by a lack of coordination and control of movements, resulting in unsteady gait, clumsiness, and difficulty with tasks that require fine motor skills, such as writing or buttoning a shirt.

Cerebellar ataxia can have various causes, including genetic mutations, acquired conditions, or as a result of damage to the cerebellum due to injury, infection, stroke, or tumors. Some common cerebellar ataxia types include spinocerebellar ataxia, Friedreich's ataxia, and alcohol-induced cerebellar degeneration.

Treatment for cerebellar ataxia depends on the underlying cause. It may involve managing the underlying condition, physical and occupational therapy to improve balance and coordination, assistive devices to aid mobility, speech therapy to address speech difficulties, and medications to manage specific symptoms or underlying conditions.

Clinical Trial

Balance training has been found to have some benefits in managing cerebellar ataxia. To determine whether a larger-scale trial comparing home-based aerobic and balance exercise is required, researchers conducted a randomized controlled trial with 19 patients in the aerobic training group and 17 in the balance training group.

Are you interested in clinical trials near you?

You can receive free notification of a trial for this, or any other condition, by completing a short confidential health profile.
Find a clinical trial near me
The trial's primary outcome was the improvement in ataxia symptoms, measured using the Scale for the Assessment and Rating of Ataxia (SARA). Secondary outcomes included safety, training adherence, and improvements in balance. At the beginning of the trial, there were no differences in baseline characteristics between the two groups.

Findings

Thirty-one participants completed the trial, and there were no serious adverse events related to the training. Training adherence was high, with over 70% compliance with the prescribed training regimen. There was a mean improvement of 1.9 SARA points in the aerobic group compared to 0.6 points in the balance group, indicating a significant improvement in ataxia symptoms with aerobic training.

Conclusion

The 6-month trial comparing home-based aerobic and balance training in cerebellar ataxia had excellent retention and adherence to exercise, and there were no serious adverse events. Home aerobic training was associated with a significant improvement in ataxia symptoms compared to balance training. Further investigation in a phase III trial will help establish the efficacy of aerobic exercise in improving ataxia symptoms.
__________



Share this article with a friend:
     


Get emailed clinical trial results in the categories of your choice:
Free subscription to clinical trial results

Whether you're healthy or have a medical condition you can participate in a clinical trial.
Signup and be matched to trials near you
This free service will notify you of current and future clinical trial matches.


This content is for informational and educational purposes only. It is not intended to provide medical advice or to take the place of such advice or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. CenTrial Data Ltd. does not take responsibility for possible health consequences of any person or persons reading or following the information in this educational content. Treatments and clinical trials mentioned may not be appropriate or available for all trial participants. Outcomes from treatments and clinical trials may vary from person to person. Consult with your doctor as to whether a clinical trial is a suitable option for your condition. Assistance from generative AI tools may have been used in writing this article.